spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  metastatic cancer 

 HSMN NewsFeed - 13 Jul 2026
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier(R)
Devices Oncology
 HSMN NewsFeed - 11 Nov 2025
New Study Shows Aliya(R) Pulsed Electric Field Ablation Achieved Local Control of Lung Tumors in Metastatic Cancer Patients and May Induce an Immune Response
Devices Oncology
 HSMN NewsFeed - 15 Mar 2024
Delcath Systems Announces $7 Million Private Placement
Biopharmaceuticals Drug Delivery Oncology Venture Capital
 HSMN NewsFeed - 21 Jun 2023
Aethlon Medical Announces Investigation of the Hemopurifier(R) for Use in Organ Transplantation
Devices
 HSMN NewsFeed - 2 Mar 2023
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian(R) MRI-Guided Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 14 Dec 2022
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 23 Aug 2022
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
Devices Oncology
 HSMN NewsFeed - 19 Jul 2022
Saitama Medical University International Medical Center Selects MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology
 HSMN NewsFeed - 23 Jun 2022
CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Jun 2022
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
Devices Oncology
 HSMN NewsFeed - 21 Sep 2021
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
Diagnostics Personnel
 HSMN NewsFeed - 29 Jun 2021
FDA Grants Fast Track Designation to CNS Pharmaceuticals for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Jan 2021
Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 3 Nov 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Devices Oncology Personnel
 HSMN NewsFeed - 27 Jul 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Jul 2020
HiberCell Announces Acquisition of Biothera Pharmaceuticals' Imprime PGG Program
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 25 Jun 2020
Long-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers
Devices Oncology
 HSMN NewsFeed - 11 Jun 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
Biopharmaceuticals Oncology Neurology FDA
 HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jul 2019
Immunicom Secures $11 Million in Series B Investment Round
Devices Venture Capital
 HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Mar 2019
Aethlon Medical, Inc. Announces Appointment of Lisa M. Boswell as Director, Quality Systems and Regulatory Affairs
Devices Personnel
 HSMN NewsFeed - 18 Dec 2018
Lilly Announces Publication of Analyses Showing Benefit of the Addition of Verzenio(R) (Abemaciclib) in Multiple Subgroups of Patients with Advanced Breast Cancer Identified as Having a More Concerning Prognosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Oct 2018
Lilly and Metastatic Breast Cancer Advocates Launch Thriver Movement to Elevate Understanding of the Daily Impact of the Disease, Encourage Public to do More for MBC
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 5 Sep 2018
Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Devices Radiology Oncology Venture Capital
 HSMN NewsFeed - 20 Aug 2018
Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Aug 2018
Oncorus(R), Inc., Names Industry Veteran Ted Ashburn as new President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2017
FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Jul 2017
FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 May 2017
Biotheranostics Appoints Don Hardison as New CEO
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 29 Mar 2017
Tyme Technologies Announces Two New Board of Director Appointments -- David Carberry and James Biehl
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Jun 2016
Elekta’s Leksell Gamma Knife Icon Cleared for Use in Japan and United States
Devices Oncology Neurosurgery Regulatory
 HSMN NewsFeed - 12 Nov 2015
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 9 Jan 2015
bioTheranostics Appoints Key Executives to Leadership Team
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 6 Oct 2014
bioTheranostics Appoints Nicolas Barthelemy as President and CEO
Diagnostics Oncology Personnel
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 18 Feb 2014
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
Diagnostics Oncology Reimbursement Personnel
 HSMN NewsFeed - 2 Jan 2014
Marina Biotech and Mirna Therapeutics Amend License Agreement for the Development of microRNA-Based Therapeutics
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 27 Aug 2013
bioTheranostics Appoints Three Key Executives
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 17 May 2013
Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients
Devices Oncology
 HSMN NewsFeed - 19 Mar 2013
bioTheranostics Adds Chief Medical Officer & Vice President of Medical, Clinical & Regulatory Affairs
Diagnostics Oncology Personnel
 HSMN NewsFeed - 24 Oct 2012
Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 11 Oct 2012
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
Diagnostics Oncology Personalized Medicine Personnel
 HSMN NewsFeed - 25 Jul 2012
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
Diagnostics Oncology Personalized Medicine Personnel
 HSMN NewsFeed - 9 Jul 2012
PsiOxus Therapeutics Secures £22 Million ($34 Million) in Series B Financing to Drive Clinical Development for Oncolytic Vaccine
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Sep 2011
Theracrine Appoints Steven Kelly as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2011
Alternative Pain Therapy for Breast, Prostate and Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Oct 2010
IsoRay Announces World's First Cesium-131 Treatment for Metastasized Lung Cancer
Devices Oncology
 HSMN NewsFeed - 24 Sep 2010
ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 12 Aug 2010
Mercator Licenses Pioneering Technology from MD Anderson Cancer Center and Closes $2M Seed Round
Biopharmaceuticals Oncology Venture Capital Licensing
 HSMN NewsFeed - 22 Apr 2010
Delcath Systems Appoints Peter J. Graham as Executive Vice President and General Counsel
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 12 Mar 2010
Delcath Systems Provides Update on Corporate Developments
Devices Oncology Drug Delivery
 HSMN NewsFeed - 1 Mar 2010
Delcath Systems Names Michael D. Dellario as Vice President, Global Marketing
Devices Oncology Drug Delivery Personnel
 HSMN NewsFeed - 23 Feb 2010
Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Dec 2009
Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board
Devices Personnel
 HSMN NewsFeed - 17 Nov 2009
bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 16 Nov 2009
Fate Therapeutics Closes $30 Million Series B Financing
Regenerative Medicine Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Oct 2009
Delcath Systems Completes Executive Management Team with Strategic New Hires
Devices Personnel
 HSMN NewsFeed - 2 Oct 2009
Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
Devices Oncology Personnel
 HSMN NewsFeed - 21 Sep 2009
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Sep 2009
Delcath Systems, Inc. Appoints David McDonald Chief Financial Officer
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 19 Aug 2009
Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
Biopharmaceuticals Onology
 HSMN NewsFeed - 6 Jul 2009
Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 2 Jun 2009
Delcath Systems Granted Third Orphan Drug Designation
Biopharmaceuticals Devices Drug Delivery Oncology FDA
 HSMN NewsFeed - 14 May 2009
Molecular Insight Pharmaceuticals, Inc. Receives European Medicines Agency Approval to Proceed With Phase 3 Development of Onalta(TM)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 May 2009
Molecular Insight Pharmaceuticals Expands Management Team by Appointing Daniel L. Peters as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2008
Algeta Appoints Andrew Kay as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2008
Elekta Announces Installation of Leksell Gamma Knife(R) Perfexion(TM) at Haukeland University Hospital in Norway
Devices Oncology Neurosurgery
 HSMN NewsFeed - 11 Sep 2008
bioMerieux Gains Critical Oncology and Theranostics Capabilities with the Acquisition of Molecular Diagnostics Company AviaraDx
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2008
Emerging Clinical Data Continues to Support CyberKnife Radiosurgery for the Treatment of Lung Cancer
Devices Oncology
 HSMN NewsFeed - 9 Jul 2008
FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Jun 2008
ABRAXANE(R) in Combination with Trastuzumab and Carboplatin Evaluated as First-Line Treatment for Patients with HER2-Positive Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2008
Combination Therapy of Solvent-Free ABRAXANE(R) and the Targeted Therapy Bevacizumab Evaluated as First-Line Treatment for Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2008
ArthroCare Unveils New Direction in Treatment of Metastatic Lesions
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 1 Apr 2008
Supratek's lead compound SP1049C is granted Orphan Drug Designation for the treatment of gastric cancer.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Mar 2008
Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Feb 2008
Altor BioScience In-Licenses Tissue Factor Antagonists from Genentech
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Dec 2007
Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Nov 2007
Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Oct 2007
Nexavar Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Oct 2007
Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
Devices Oncology
 HSMN NewsFeed - 23 Oct 2007
NCCN Updates Non-Small Cell Lung Cancer Guidelines
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Oct 2007
Alethia Biotherapeutics Inc. Announces in-Licensing of Family of Monoclonal Antibodies to Treat Metastatic Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 18 Sep 2007
Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
Devices Oncology
 HSMN NewsFeed - 14 Aug 2007
Misonix Highlights Recent Duke University Study Revealing Significant New Cancer Treatment May Be Possible with HIFU Technology
Devices Oncology
 HSMN NewsFeed - 30 Jul 2007
Gamma Knife(R) Surgery Best Choice, Says Cancer Patient
Devices Oncology Neurosurgery
 HSMN NewsFeed - 27 Mar 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Metastatic Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jan 2007
Phase II clinical trial of Biomira's PX-12 in patients with advanced pancreatic cancer now open for patient enrollment
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Nov 2006
Pharmacyclics Announces Presentation of Pooled Analysis of Xcytrin(R) for Lung Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Oct 2006
Biomira Announces Acquisition of ProlX Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Oct 2006
GammaCan International, Announces Appointment of Lynn Schuchter M.D. to its Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Sep 2006
Metastatix Completes Series a Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2006
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 7 Sep 2006
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 6 Jul 2006
Pathwork Diagnostics Formed From Venture-Backed Acquisition
Diagnostics Venture Capital Personnel
Return to NewsFeed  

 Additional items found! 51

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 51 additional stories matching:
metastatic cancer
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!